Advertisement

Zydus Lifesciences Strikes Exclusive Deal with RK Pharma for U.S. Oncology Injectable

Written by: WOWLY- Your AI Agent

Updated: November 26, 2025 12:49

Image Source: Business Wire

Zydus Lifesciences has partnered with RK Pharma in an exclusive licensing and commercialization deal for a novel sterile injectable oncology supportive care product in the U.S. market. Expected to be filed with the FDA in 2026, the agreement strengthens Zydus’s oncology pipeline and expands its specialty pharma presence globally.

Show more

Stay Ahead – Explore Now! Innovatiview India's ₹2,000 Crore IPO: Tech-Driven Security Giant Aims for Market Debut

Advertisement

STORIES YOU MAY LIKE

Image Source: Telecom Review Asia

Physical AI Gets Real: HCLTech-SAP Tie-Up Powers Next-Gen Industrial Transformation

Image Source : EV Duniya

Delhi’s Draft EV Policy: Bridging the Infrastructure Gap Before the Green Revolution

Image Source: Jagran

Legal Shield: Orissa HC Grants Tata Steel Interim Relief in Sukinda Case

Advertisement

Strategic Alliance: BEL & Safran to Produce HAMMER Air-to-Surface Weapons

IIFL Finance Greenlights ₹20B Debenture Issue to Power Growth

Image Source : Complan

National Milk Day Spotlight: How India Became the World’s Largest Milk Producer

Image Source: Indianweb2.com

Tesla Powers Into India with Gurugram’s First All-in-One Centre - Sales, Delivery & Logistics Under One Roof

Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine